Kinetic Analysis of the Interaction between Nonsteroidal Anti-inflammatory Drugs and Cyclooxygenase-2 Using Wavelength Modulation Surface Plasmon Resonance

被引:0
|
作者
Liu Xia [1 ]
Li Ying [1 ]
Lin Zhao [1 ]
机构
[1] Hunan Agr Univ, Coll Food Sci & Technol, Hunan Prov Key Lab Food Sci & Biotechnol, Changsha 410128, Hunan, Peoples R China
基金
国家高技术研究发展计划(863计划);
关键词
surface plasmon resonance; biosensor; cyclooxygenase; drug; affinity; BIOSENSOR; PREDICTION; BOVINE;
D O I
10.1002/cjoc.201190046
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A surface plasmon resonance (SPR) biosensor based on wavelength modulation technology was developed and validated for the kinetic analysis of the interactions between two nonsteroidal anti-inflammatory drugs (NSAIDs) and cyclooxygenase-2 (COX-2). After the effect of different concentration COX-2 on the binding capacity of the SPR biosensor surface was studied, the COX-2 was immobilized covalently onto the biosensor surface using a standard amine coupling method. The affinity constants for indomethacin, ketoprofen binding to COX-2 are 7.5 X 10(3) L/mol and 9.25X10(3) L/mol, respectively. The biosensor surface can be regenerated after being rinsed with 0.01 mol/L NaOH, and the biosensor can be used repeatedly. These indicated that the wavelength modulation SPR biosensor has the potential application in the fields of pharmacokinetics, pharmacodynamics and drug discovery.
引用
收藏
页码:165 / 170
页数:6
相关论文
共 50 条
  • [1] An update on nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors
    Williams G.W.
    Current Pain and Headache Reports, 2005, 9 (6) : 377 - 389
  • [2] Cyclooxygenase-2 Inhibitors, Nonsteroidal Anti-inflammatory Drugs, and Cardiovascular Risk
    Vardeny, Orly
    Solomon, Scott D.
    CARDIOLOGY CLINICS, 2008, 26 (04) : 589 - +
  • [3] Balancing Risks and Benefits of Cyclooxygenase-2 Selective Nonsteroidal Anti-Inflammatory Drugs
    Scheiman, James M.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2009, 38 (02) : 305 - +
  • [4] Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional nonsteroidal anti-inflammatory drugs
    Hermann, Matthias
    Ruschitzka, Frank
    ANNALS OF MEDICINE, 2007, 39 (01) : 18 - 27
  • [5] Acetaminophen, Nonsteroidal Anti-Inflammatory Drugs, and Cyclooxygenase-2 Selective Inhibitors: An Update
    Gupta, Anil
    Jakobsson, Jan
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2014, 134 (04) : 24S - 31S
  • [6] Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs
    Cryer, B
    Feldman, M
    AMERICAN JOURNAL OF MEDICINE, 1998, 104 (05): : 413 - 421
  • [7] Cardiovascular risk and inhibition of cyclooxygenase: traditional nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors
    Campanini, M.
    Mathieu, G.
    ITALIAN JOURNAL OF MEDICINE, 2007, 1 (01) : 37 - 54
  • [8] Cyclooxygenase-2, Asymmetric Dimethylarginine, and the Cardiovascular Hazard From Nonsteroidal Anti-Inflammatory Drugs
    Ricciotti, Emanuela
    Castro, Cecilia
    Tang, Soon Yew
    Briggs, William T. E.
    West, James A.
    Malik, Dania
    Rhoades, Seth D.
    Meng, Hu
    Li, Xuanwen
    Lahens, Nicholas F.
    Sparks, Jeffrey A.
    Karlson, Elizabeth W.
    Weljie, Aalim M.
    Griffin, Julian L.
    FitzGerald, Garret A.
    CIRCULATION, 2018, 138 (21) : 2367 - 2378
  • [9] Nonsteroidal anti-inflammatory drugs (NSAIDs), cyclooxygenase-2 polymorphisms, and breast cancer risk
    Menegaux, Florence
    Truong, Therese
    Ajmia, Florian
    Anger, Antoinette
    Mulot, Claire
    Laurent-Puig, Pierre
    Cordina-Duverger, Emilie
    Guenel, Pascal
    CANCER RESEARCH, 2013, 73 (08)
  • [10] Exacerbation of inflammatory bowel disease by nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors: Fact or fiction?
    Guslandi, Mario
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (10) : 1509 - 1510